HUM vs UPB
Humana Inc (HUM) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. UPB currently screens at market cap $407.3M.
Not investment advice. Open the HUM and UPB stock pages for the full models.
Not investment advice.